Dr. Erica Stringer-Reasor, MD
Claim this profileUniversity of Alabama at Birmingham
Expert in Breast Cancer
Studies Pancreatic Cancer
12 reported clinical trials
31 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Pancreatic Cancer
Affiliated Hospitals
Clinical Trials Erica Stringer-Reasor, MD is currently running
New Treatments
for Metastatic Breast Cancer
This trial is testing different medicines or combinations of medicines to treat cancer. It focuses on patients with certain solid tumors, including breast cancer. The study aims to find the safest and most effective dose and then tests that dose on more patients to see if it works. Dinaciclib is being evaluated for its potential in combination therapies for breast cancer.
Recruiting1 award Phase 110 criteria
GLSI-100
for HER2 Positive Breast Cancer
This is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects who are at high risk for disease recurrence and have completed both neoadjuvant and postoperative adjuvant standard of care therapy. Treatment consists of 6 intradermal injections, Primary Immunization Series (PIS), over the first 6 months of treatment and 5 booster intradermal injections spaced 6 months apart. A third open-label arm will explore GLSI-100 immunotherapy in non-HLA-A\*02 positive and HER2/neu positive subjects.
Recruiting1 award Phase 36 criteria
More about Erica Stringer-Reasor, MD
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Erica Stringer-Reasor, MD has experience with
- Trastuzumab
- Ladiratuzumab Vedotin
- Ribociclib
- Palbociclib
- Niraparib
- Pembrolizumab
Breakdown of trials Erica Stringer-Reasor, MD has run
Breast Cancer
Pancreatic Cancer
Breast cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erica Stringer-Reasor, MD specialize in?
Erica Stringer-Reasor, MD focuses on Breast Cancer and Pancreatic Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Erica Stringer-Reasor, MD currently recruiting for clinical trials?
Yes, Erica Stringer-Reasor, MD is currently recruiting for 4 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Erica Stringer-Reasor, MD has studied deeply?
Yes, Erica Stringer-Reasor, MD has studied treatments such as Trastuzumab, ladiratuzumab vedotin, Ribociclib.
What is the best way to schedule an appointment with Erica Stringer-Reasor, MD?
Apply for one of the trials that Erica Stringer-Reasor, MD is conducting.
What is the office address of Erica Stringer-Reasor, MD?
The office of Erica Stringer-Reasor, MD is located at: University of Alabama at Birmingham, Birmingham, Alabama 35294 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.